解冻
发表于 2025-3-25 04:19:55
http://reply.papertrans.cn/87/8604/860348/860348_21.png
Abominate
发表于 2025-3-25 09:20:44
http://reply.papertrans.cn/87/8604/860348/860348_22.png
放气
发表于 2025-3-25 15:02:14
2196-9906to inhibit STATs in the context of various cancers, covering the full spectrum of therapeutic approaches to inhibiting STATs, and presenting emerging data from clinical trials..978-3-319-82701-8978-3-319-42949-6Series ISSN 2196-9906 Series E-ISSN 2196-9914
Shuttle
发表于 2025-3-25 17:13:35
STATs in Health and Disease, to mediate a diverse range of functions. This chapter provides an overview of the STAT protein family, their structure, mode of activation, specificity, variants and negative regulation along with their multiple roles in both normal biology as well as the etiology of disease.
Mast-Cell
发表于 2025-3-25 21:20:58
Inhibitors of Upstream Inducers of STAT Activation,s or small molecules and so represent attractive candidates for therapeutic development. This chapter details several promising agents that target receptors — both receptor tyrosine kinases and cytokine receptors — and downstream kinases that activate STATs in cancer, including EGFR, VEGFR, IL-6R, SRC and ABL.
Psa617
发表于 2025-3-26 02:55:21
http://reply.papertrans.cn/87/8604/860348/860348_26.png
hieroglyphic
发表于 2025-3-26 07:36:30
978-3-319-82701-8Springer International Publishing Switzerland 2016
Asymptomatic
发表于 2025-3-26 11:46:26
http://reply.papertrans.cn/87/8604/860348/860348_28.png
medium
发表于 2025-3-26 12:52:37
http://reply.papertrans.cn/87/8604/860348/860348_29.png
Gnrh670
发表于 2025-3-26 20:50:26
Cancer Drug Discovery and Developmenthttp://image.papertrans.cn/s/image/860348.jpg